Literature DB >> 12700381

Medicare and drug pricing.

John K Iglehart.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12700381     DOI： 10.1056/NEJMhpr035135

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country.

Authors:  Dragan R Milovanovic; Radomir Pavlovic; Miroslav Folic; Slobodan M Jankovic
Journal:  Eur J Clin Pharmacol       Date:  2004-04-01       Impact factor: 2.953

2.  Publication patterns of cancer cost-effectiveness studies presented at major conferences.

Authors:  K K Chan; E Siu; L Mozessohn; M C Cheung
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

3.  Physician response to financial incentives when choosing drugs to treat breast cancer.

Authors:  Andrew J Epstein; Scott J Johnson
Journal:  Int J Health Care Finance Econ       Date:  2012-11-03

4.  Medicare reimbursement and the use of biologic agents: incentives, access, the public good, and optimal care.

Authors:  Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.